Tizanidine
- Product NDC
- 0378-0724
- 11-digit product format
- 003780724
- Labeler code
- 0378
- Product ID
- 0378-0724_b60798f1-a7ba-4ab7-9ab6-81e650101b45
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- ANDA076354
- Marketing category
- ANDA
- Marketing start
- 2003-05-06
- Marketing end
- 2021-02-28
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0378-0724-19 | 00378072419 | 150 TABLET in 1 BOTTLE, PLASTIC (0378-0724-19) | 150 tablet | 2003-05-06 | 2021-02-28 | No | No | Current |